SynAct Pharma AB: ifrs:DilutedEarningsLossPerShare
| Value | {"amount": -3.6} |
|---|---|
| Period | 2022-01-01 – 2022-12-31 |
| Status | current |
| Entity | SynAct Pharma AB |
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
Retrieved: 2026-08-23T23:56:10.380701+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/6d95948b-c6d8-401f-8fb3-3ecdf936d957
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
esef:549300RRYIEFEQ72N546:2023-12-31Retrieved: 2026-08-23T23:56:10.380701+02:00
Raw response sha256:
c6bdc5c5472ae13ac80f56093c8f1d77…Cite as: FACTANKER, https://factanker.com/fact/6d95948b-c6d8-401f-8fb3-3ecdf936d957
History
- no predecessors — first report